Acute Coronary Syndrome Part 2 Flashcards
What different life factors give points in the TIMI risk scores?
- over 65 y/o
- more than 3 risk factors for CAD
- prior coronary stenosis
- > 50% ST deviation on an ECG
- more than 2 anginal events in prior 24 hours
- use of aspirin in prior 7 days
- elevated cardiac biomarkers
What are some other high risk factors for ACS?
- hemodynamic instability
- refractory angina
- recurrent angina or ischemia at rest
- signs and symptoms of HF
- sustained VT
- ECG changes (new ST depression)
- prior PCI/CABG
What patients are generally referred for a CABG?
- high risk patients with multi-vessel disease may be referred for a CABG (hold DAPT 5-7 days prior to surgery if possible)
When is an angiography/PCI revascularization indicated in patients?
for high risk patients with a TIMI risk score of >2, or in the presence of other high risk characteristics
UN/STEMI patients who underwent early invasive strategy with PCI should receive what?
- DAPT (as would a STEMI patient receive)
How long should DAPT therapy be recommended in all ACS patients?
- recommend DAPT therapy for 1 year in all ACS patients
over 1 year therapy is controversial
How long should DAPT therapy be recommended in all ACS patients?
- recommend DAPT therapy for 1 year in all ACS patients
over 1 year therapy is controversial
If a patient is at very high risk of having another infarction, what should be used: clopridogrel or ticagrelor?
- ticagrelor
there is a reduction in endpoint death from CV causes, nonfatal MI or stroke in the ticagrelor group
What are GP IIb/IIIa inhibitors?
they are potent anti-platelet agents
Describe the action of GP IIb/IIIa agents?
- they block the binding of fibrinogen to GP IIb/IIIa receptors on the platelet surface, therefore inhibiting platelet aggregation
What are examples of the GP IIIb/IIIa receptor antagonists?
- abciximab, epifibatide, tirofiban
When do GP IIb/IIIa inhibitors have benefit?
- they have demonstrated benefit in reducing death/MI in patients who have undergone PCI (early invasive strategy)
What anticoagulant is the standard to give?
- LMWH is the standard to give in patients (long acting and has renal elimination however- disadvantage)
What needs to be monitored in patients receiving anticoagulant therapy?
- need to monitor signs of bleeding, Hbg and platelets
What is the action of fondaparinux?
- indirect acting factor Xa inhibitor
- we do not usually give this unless the person is at a very high risk of bleeding